These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 10411168)
21. Pharmacokinetic evaluation of mycophenolate mofetil for pemphigus. Doukaki S; Pistone G; Aricò M; Bongiorno MR Expert Opin Drug Metab Toxicol; 2011 Feb; 7(2):237-44. PubMed ID: 21192770 [TBL] [Abstract][Full Text] [Related]
22. Jaw Pain in a Pemphigus Patient on Prednisolone, Mycophenolate Mofetil and Denosumab. Yeo PM; Ang CC Ann Acad Med Singap; 2017 Aug; 46(8):329-330. PubMed ID: 28920136 [No Abstract] [Full Text] [Related]
23. Pemphigus foliaceus in an adolescent. Adah A; Hill K; Wyatt J; Didion L J Pediatr; 2014 Nov; 165(5):1062.e1. PubMed ID: 25151193 [No Abstract] [Full Text] [Related]
24. A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of pemphigus. Beissert S; Werfel T; Frieling U; Böhm M; Sticherling M; Stadler R; Zillikens D; Rzany B; Hunzelmann N; Meurer M; Gollnick H; Ruzicka T; Pillekamp H; Junghans V; Luger TA Arch Dermatol; 2006 Nov; 142(11):1447-54. PubMed ID: 17116835 [TBL] [Abstract][Full Text] [Related]
25. Localized Kaposi's sarcoma in a patient with pemphigus vulgaris. Avalos-Peralta P; Herrera A; Ríos-Martín JJ; Pérez-Bernal AM; Moreno-Ramírez D; Camacho F J Eur Acad Dermatol Venereol; 2006 Jan; 20(1):79-83. PubMed ID: 16405614 [TBL] [Abstract][Full Text] [Related]
26. Randomized controlled open-label trial of four treatment regimens for pemphigus vulgaris. Chams-Davatchi C; Esmaili N; Daneshpazhooh M; Valikhani M; Balighi K; Hallaji Z; Barzegari M; Akhyani M; Ghodsi SZ; Seirafi H; Nazemi MJ; Mortazavi H; Mirshams-Shahshahani M J Am Acad Dermatol; 2007 Oct; 57(4):622-8. PubMed ID: 17583373 [TBL] [Abstract][Full Text] [Related]
36. Mycophenolate mofetil: a new therapeutic option in the treatment of blistering autoimmune diseases. Grundmann-Kollmann M; Korting HC; Behrens S; Kaskel P; Leiter U; Krähn G; Kerscher M; Peter RU J Am Acad Dermatol; 1999 Jun; 40(6 Pt 1):957-60. PubMed ID: 10365927 [TBL] [Abstract][Full Text] [Related]
37. Treatment of cicatricial pemphigoid with mycophenolate mofetil as a steroid-sparing agent. Megahed M; Schmiedeberg S; Becker J; Ruzicka T J Am Acad Dermatol; 2001 Aug; 45(2):256-9. PubMed ID: 11464188 [TBL] [Abstract][Full Text] [Related]
38. [Open trial of mycophenolate mofetil in the treatment of resistant pemphigus vulgaris]. Chams-Davatchi C; Nonahal Azar R; Daneshpazooh M; Valikhani M; Hallaji Z; Barzegari M; Firouz AR; Zakeri M Ann Dermatol Venereol; 2002 Jan; 129(1 Pt 1):23-5. PubMed ID: 11937925 [TBL] [Abstract][Full Text] [Related]
39. Red blood cell anemia in a patient with pemphigus vulgaris induced by the use of mycophenolate mofetil and prednisone. Scheinfeld N J Dermatolog Treat; 2007; 18(4):243-5. PubMed ID: 17671884 [TBL] [Abstract][Full Text] [Related]
40. Treatment of pemphigus vulgaris and pemphigus foliaceus with mycophenolate mofetil. Mimouni D; Anhalt GJ; Cummins DL; Kouba DJ; Thorne JE; Nousari HC Arch Dermatol; 2003 Jun; 139(6):739-42. PubMed ID: 12810504 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]